Opening in Bureauify…
ClosedGrantWon by 3I Diagnostics, Inc.SBIR Phase I SBIR

SBIR Phase I: Development and assessment of a diagnostic platform for rapid identification of COVID-19 patients without using custom reagents

National Science Foundation

Closed
NAICS 621999
Source: sbir_sttr
OverviewIntelligenceProposals

Key Details

Posted Date
Response Deadline
NAICS Code
621999
Source
sbir_sttr
Award Amount
$256,000
Awarded To
3I Diagnostics, Inc.

Description

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to deploy a diagnostic to rapidly and inexpensively detect COVID-19 infections. Beyond the short-term goal of identifying COVID-19 patients, the t

Key Dates

Posted:Deadline:

Frequently Asked Questions

Is this grant still open?+
No — the response deadline for this grant has passed (December 31, 2020). Browse other active National Science Foundation opportunities on Bureauify.
How do I apply for this grant?+
Review the full solicitation documents on the source website (SAM.gov or Grants.gov), prepare your proposal per the instructions, and submit before the deadline. Use Bureauify to track the opportunity and get reminders.
Who won this grant?+
This grant was awarded to 3I Diagnostics, Inc. for $256,000. Use Bureauify to analyze this vendor's contract history and win patterns.

Track This Grant

Get alerts and track updates with Bureauify.

Track in BureauifyView on sbir_sttr

Intelligence

  • Win probability analysis
  • Competitive landscape
  • Incumbent analysis
  • Price-to-win estimate
  • Similar awards history
Open in Bureauify for full intelligence →

Data sourced from sbir_sttr

Search Government Records

100M+ government records — search across all categories

SBIR Phase I: Development and assessment of a diagnostic pla — National Science Foundation | Bureauify